- Home
- NTBL
NTBL
Notable Labs Ltd.
as 07-26-2024 4:00pm EST
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | FOSTER CITY |
| Market Cap: | 6.6M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 179.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $10.78 | Next Earning Date: | 08-15-2024 |
| Revenue: | $311,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Notable Labs Ltd. (NTBL)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FR Capital Holdings, L.P. | NTBL | Jan 2 '24 | Sell | $1.89 | 50,000 | $94,670.00 | 880,489 | SEC Form 4 | |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 28 '23 | Sell | $2.01 | 21,500 | $43,146.20 | 936,489 | SEC Form 4 |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 28 '23 | Sell | $1.83 | 6,000 | $10,989.60 | 930,489 | SEC Form 4 |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 26 '23 | Sell | $2.16 | 11,456 | $24,765.58 | 978,022 | SEC Form 4 |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 26 '23 | Sell | $2.08 | 20,033 | $41,694.68 | 957,989 | SEC Form 4 |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 21 '23 | Sell | $2.51 | 2,867 | $7,191.01 | 1,034,478 | SEC Form 4 |
| FR Capital Holdings, L.P. | NTBL | 10% Owner | Dec 21 '23 | Sell | $2.41 | 45,000 | $108,283.50 | 989,478 | SEC Form 4 |
Latest Notable Labs Ltd. News
NTBL Breaking Stock News: Dive into NTBL Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
CNW Group
2 months ago
Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024
ACCESSWIRE
2 months ago
Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge
Business Insider
2 months ago
Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies
GlobeNewswire
2 months ago
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
Motley Fool
2 months ago
Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger
CNW Group
2 months ago
Unifor members vote to strike at Manitoba Hydro
AFP
2 months ago
Croatia beat Portugal in Euro 2024 warm-up friendly
Compare NTBL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NTBL Notable Labs Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.